FTSE100 consolidates gains as mood brightens
Investors shrug off 'We're done for' predictions to push shares higher
Company
LON:INS
Instem PLC is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for study management, regulatory submissions, clinical trial acceleration, and informatics-based insight generation. The company's solutions are in use by over 700 customers worldwide, including all of the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster.
109 stories · page 6 of 6
Investors shrug off 'We're done for' predictions to push shares higher
The company said revenues for the year ended December were up £2.4mln and ahead of expectations at £15.8mln.
Archive
The end of quarter is approaching so companies were rushing out end-June trading updates, leading to a very heavy news day.
ALPHADAS product suite, the result of an acquisition of Logos Technologies in 2013, is gaining traction.
Investments and investor services
Accesso, which takes the waiting out of queuing at theme parks, cheered investors today by raising profits guidance.
Instem told investors it expected trading for the year to December 31 to be in line with market expectations.